HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heesung Chung Selected Research

Melanoma (Melanoma, Malignant)

10/2021Extracellular Vesicles from Korean Codium fragile and Sargassum fusiforme Negatively Regulate Melanin Synthesis.
1/2018Keratinocytes negatively regulate the N-cadherin levels of melanoma cells via contact-mediated calcium regulation.
3/2016FK506 regulates pigmentation by maturing the melanosome and facilitating their transfer to keratinocytes.
1/2015(E)-4-(3,4-Dimethoxyphenyl)but-3-en-1-ol Enhances Melanogenesis through Increasing Upstream Stimulating Factor-1-Mediated Tyrosinase Expression.
8/2014Keratinocyte-derived laminin-332 protein promotes melanin synthesis via regulation of tyrosine uptake.
5/2014Syndecan-2 regulates melanin synthesis via protein kinase C βII-mediated tyrosinase activation.
6/2012Melanocortin 1 receptor regulates melanoma cell migration by controlling syndecan-2 expression.
4/2011Keratinocyte-derived laminin-332 promotes adhesion and migration in melanocytes and melanoma.
10/2009Syndecan-2 regulates the migratory potential of melanoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heesung Chung Research Topics

Disease

9Melanoma (Melanoma, Malignant)
10/2021 - 10/2009
8Neoplasms (Cancer)
08/2020 - 10/2009
4Breast Neoplasms (Breast Cancer)
08/2020 - 03/2015
4Inflammation (Inflammations)
01/2017 - 03/2011
3Neoplasm Metastasis (Metastasis)
08/2020 - 12/2016
3Colonic Neoplasms (Colon Cancer)
01/2017 - 01/2010
2Triple Negative Breast Neoplasms
08/2020 - 10/2019
2Carcinogenesis
01/2016 - 10/2009
2Carcinoma (Carcinomatosis)
01/2010 - 10/2009
1Colitis
01/2017
1Hypoxia (Hypoxemia)
01/2017
1Adenocarcinoma
12/2016
1Vitiligo
03/2016
1Hypopigmentation (Hypomelanosis)
01/2015
1Nevus (Nevi)
10/2009

Drug/Important Bio-Agent (IBA)

6Melanins (Melanin)IBA
10/2021 - 10/2009
6Syndecan-2IBA
01/2017 - 10/2009
6Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
01/2017 - 10/2009
3Melanocyte-Stimulating Hormones (MSH)IBA
10/2021 - 06/2012
2Proteins (Proteins, Gene)FDA Link
10/2021 - 10/2009
2ArrestinIBA
08/2020 - 10/2019
2Cadherins (E-Cadherin)IBA
01/2018 - 12/2016
2SyndecansIBA
01/2016 - 03/2011
2Small Interfering RNA (siRNA)IBA
08/2014 - 05/2014
2Fibronectins (Fibronectin)IBA
08/2014 - 04/2011
1Monophenol Monooxygenase (Tyrosinase)IBA
10/2021
1Microphthalmia-Associated Transcription FactorIBA
10/2021
1Fluorouracil (Carac)FDA LinkGeneric
08/2020
1DNA (Deoxyribonucleic Acid)IBA
08/2020
1MicroRNAs (MicroRNA)IBA
08/2020
1UracilIBA
08/2020
1Tannic AcidFDA Link
01/2019
1CalciumIBA
01/2018
1AzoxymethaneIBA
01/2017
1Dextran SulfateIBA
01/2017
1Protein Kinase InhibitorsIBA
01/2017
1p38 Mitogen-Activated Protein KinasesIBA
01/2017
1Conditioned Culture MediaIBA
12/2016
1Tacrolimus (Prograf)FDA LinkGeneric
03/2016
1eumelaninIBA
03/2016
1baicaleinIBA
03/2015
1baicalinIBA
03/2015
1Tyrosine (L-Tyrosine)FDA Link
08/2014
1LigandsIBA
06/2012
1Type 1 Melanocortin ReceptorIBA
06/2012
1adhesion receptorIBA
01/2010
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
10/2009
1alpha-MSHIBA
10/2009

Therapy/Procedure

2Therapeutics
08/2020 - 01/2019